Article Versions Notes

Alminderej F, Ghannay S, Elsamani MO, Alhawday F, Albadri AEAE, Elbehairi SEI, Alfaifi MY, Kadri A, Aouadi K. In Vitro and In Silico Evaluation of Antiproliferative Activity of New Isoxazolidine Derivatives Targeting EGFR: Design, Synthesis, Cell Cycle Analysis, and Apoptotic Inducers. Pharmaceuticals. 2023; 16(7):1025. https://doi.org/10.3390/ph16071025

Alminderej, Fahad, Siwar Ghannay, Mohamed O. Elsamani, Fahad Alhawday, Abuzar E. A. E. Albadri, Serag Eldin I. Elbehairi, Mohammad Y. Alfaifi, Adel Kadri, and Kaïss Aouadi. 2023. "In Vitro and In Silico Evaluation of Antiproliferative Activity of New Isoxazolidine Derivatives Targeting EGFR: Design, Synthesis, Cell Cycle Analysis, and Apoptotic Inducers" Pharmaceuticals 16, no. 7: 1025. https://doi.org/10.3390/ph16071025

Alminderej, F., Ghannay, S., Elsamani, M. O., Alhawday, F., Albadri, A. E. A. E., Elbehairi, S. E. I., Alfaifi, M. Y., Kadri, A., & Aouadi, K. (2023). In Vitro and In Silico Evaluation of Antiproliferative Activity of New Isoxazolidine Derivatives Targeting EGFR: Design, Synthesis, Cell Cycle Analysis, and Apoptotic Inducers. Pharmaceuticals, 16(7), 1025. https://doi.org/10.3390/ph16071025